-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$3.67979.41% Upside
X4 Pharmaceuticals, Inc. Frequently Asked Questions
-
What analysts cover X4 Pharmaceuticals, Inc.?
X4 Pharmaceuticals, Inc. has been rated by research analysts at Cantor Fitzgerald, Piper Sandler, H.C. Wainwright in the past 90 days.